Jérôme Kerzerho

489 total citations
18 papers, 393 citations indexed

About

Jérôme Kerzerho is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Jérôme Kerzerho has authored 18 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Jérôme Kerzerho's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (6 papers) and Asthma and respiratory diseases (3 papers). Jérôme Kerzerho is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (6 papers) and Asthma and respiratory diseases (3 papers). Jérôme Kerzerho collaborates with scholars based in France, United States and Germany. Jérôme Kerzerho's co-authors include Omid Akbari, Natacha Szely, Vincent Lombardi, Anneliese O. Speak, Bernard Maillère, Éric Tartour, Jonathan Lam, Hadi Maazi, Jacques Van Snick and Olivier Adotévi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Jérôme Kerzerho

18 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Kerzerho France 11 283 101 83 82 27 18 393
Scott A. Wetzel United States 13 382 1.3× 110 1.1× 39 0.5× 82 1.0× 15 0.6× 18 500
Maria Quaranta Italy 9 247 0.9× 82 0.8× 107 1.3× 44 0.5× 28 1.0× 16 479
Mingjing Hu Australia 4 168 0.6× 71 0.7× 34 0.4× 69 0.8× 26 1.0× 6 304
Diego Martínez Argentina 7 172 0.6× 139 1.4× 47 0.6× 30 0.4× 29 1.1× 11 353
Martina Rocchi Italy 7 169 0.6× 167 1.7× 36 0.4× 60 0.7× 37 1.4× 11 398
Aysefa Doganci Germany 8 199 0.7× 42 0.4× 147 1.8× 53 0.6× 19 0.7× 12 324
Toshihiro Matsukawa Japan 9 133 0.5× 59 0.6× 55 0.7× 62 0.8× 21 0.8× 25 301
Jeffrey Panella United States 8 227 0.8× 179 1.8× 44 0.5× 86 1.0× 23 0.9× 8 469
Luisa Senra Switzerland 4 361 1.3× 62 0.6× 87 1.0× 64 0.8× 16 0.6× 5 473

Countries citing papers authored by Jérôme Kerzerho

Since Specialization
Citations

This map shows the geographic impact of Jérôme Kerzerho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Kerzerho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Kerzerho more than expected).

Fields of papers citing papers by Jérôme Kerzerho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Kerzerho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Kerzerho. The network helps show where Jérôme Kerzerho may publish in the future.

Co-authorship network of co-authors of Jérôme Kerzerho

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Kerzerho. A scholar is included among the top collaborators of Jérôme Kerzerho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Kerzerho. Jérôme Kerzerho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nabeshima, Akira, Makoto Endo, А. В. Новиков, et al.. (2025). A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltration. PubMed. 3(1). 5–5. 3 indexed citations
2.
Dardelle, Flavien, et al.. (2024). Diversity, Complexity, and Specificity of Bacterial Lipopolysaccharide (LPS) Structures Impacting Their Detection and Quantification. International Journal of Molecular Sciences. 25(7). 3927–3927. 8 indexed citations
3.
Chettab, Kamel, Chantel Fitzsimmons, А. В. Новиков, et al.. (2023). A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Frontiers in Immunology. 14. 1066402–1066402. 6 indexed citations
4.
Новиков, А. В., Kamel Chettab, Charles Dumontet, et al.. (2023). A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Cancers. 15(18). 4635–4635. 11 indexed citations
5.
Bompas, Emmanuelle, Denis Cochonneau, Jérôme Kerzerho, et al.. (2023). Effect of dual properties of regorafenib in osteosarcoma on tumor progression and bone parameters in mouse preclinical models.. Journal of Clinical Oncology. 41(16_suppl). e23501–e23501. 1 indexed citations
6.
Gallais, Yann, Divor Kiseljak, Florian Wurm, et al.. (2020). Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes. Cellular and Molecular Immunology. 18(5). 1323–1325. 3 indexed citations
7.
Onodi, Fanny, Nadine Benhamouda, Fabien Gueugnon, et al.. (2018). High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes. Frontiers in Oncology. 8. 517–517. 24 indexed citations
8.
Laheurte, Caroline, Jeanne Galaine, Magalie Dosset, et al.. (2016). Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+Th1 responses against telomerase in cancer patients. OncoImmunology. 5(5). e1137416–e1137416. 18 indexed citations
9.
Laheurte, Caroline, Jeanne Galaine, Magalie Dosset, et al.. (2016). Immunoprevalence and magnitude of HLA-DP versus HLA-DR-restricted spontaneous CD4 Th1 responses against telomerase in cancer patients. Faculty of 1000 Research Ltd. 5. 2 indexed citations
10.
Kerzerho, Jérôme, Patricia Anthony, Wendy J. Mack, et al.. (2015). Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(2). 172–180. 5 indexed citations
11.
Kerzerho, Jérôme, et al.. (2013). The Signal Peptide of the Tumor-shared Antigen Midkine Hosts CD4+ T Cell Epitopes. Journal of Biological Chemistry. 288(19). 13370–13377. 13 indexed citations
12.
Kerzerho, Jérôme, Hadi Maazi, Anneliese O. Speak, et al.. (2012). Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. Journal of Allergy and Clinical Immunology. 131(4). 1048–1057.e2. 83 indexed citations
13.
Lombardi, Vincent, Anneliese O. Speak, Jérôme Kerzerho, Natacha Szely, & Omid Akbari. (2012). CD8α+β− and CD8α+β+ plasmacytoid dendritic cells induce Foxp3+ regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunology. 5(4). 432–443. 69 indexed citations
14.
Kerzerho, Jérôme, Esther Dawen Yu, Carolina Barra, et al.. (2012). Structural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory Properties. The Journal of Immunology. 188(5). 2254–2265. 24 indexed citations
15.
Kerzerho, Jérôme, Natacha Szely, Hellmuth‐Alexander Meyer, et al.. (2011). Effects of Systemic versus Local Administration of Corticosteroids on Mucosal Tolerance. The Journal of Immunology. 188(1). 470–476. 17 indexed citations
16.
Lombardi, Vincent C., Philippe Stock, Jérôme Kerzerho, et al.. (2010). A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity. The Journal of Immunology. 184(4). 2107–2115. 41 indexed citations
17.
Kerzerho, Jérôme, Olivier Adotévi, Florence Castelli, et al.. (2010). The Angiogenic Growth Factor and Biomarker Midkine Is a Tumor-Shared Antigen. The Journal of Immunology. 185(1). 418–423. 30 indexed citations
18.
Wang, Xiaofei, Jérôme Kerzerho, Olivier Adotévi, et al.. (2008). Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients. The Journal of Immunology. 181(1). 431–439. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott A. Wetzel Breakdown of academic impact, for papers by Maria Quaranta Breakdown of academic impact, for papers by Mingjing Hu Breakdown of academic impact, for papers by Diego Martínez Breakdown of academic impact, for papers by Martina Rocchi Breakdown of academic impact, for papers by Aysefa Doganci Breakdown of academic impact, for papers by Toshihiro Matsukawa Breakdown of academic impact, for papers by Jeffrey Panella Breakdown of academic impact, for papers by Luisa Senra
Rankless by CCL
2026